#glaxosmithkline — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #glaxosmithkline, aggregated by home.social.
-
Defend all jobs at GSK’s Dresden vaccine plant in Germany!
GSK plant in Dresden On September 11, British pharmaceutical giant GlaxoSmithKline (GSK) announced it would close its vaccine…
#EuropeSays #Britain #Europe #EU #GSK #BigPharma #GlaxoSmithKline #IGBCE #IWA-RFC #PharmaceuticalIndustry #plantclosure #Saxony #workscouncil
https://www.europesays.com/britain/130443/ -
https://www.europesays.com/britain/130443/ Defend all jobs at GSK’s Dresden vaccine plant in Germany! #BigPharma #GlaxoSmithKline #GSK #IGBCE #IWARFC #PharmaceuticalIndustry #PlantClosure #Saxony #WorksCouncil
-
GSK lays off over 500 employees in Poland
The whole IT department is getting closed down.
https://epoznan.pl/news-news-180223-gsk_zwalnia_caly_dzial_it_w_poznaniu_kilkaset_osob_straci_prace
#GSK #GlaxoSmithKline #bigpharma #pharma #technology #layoffs #Poland #Polska #Poznań
-
GSK lays off over 500 employees in Poland
The whole IT department is getting closed down.
https://epoznan.pl/news-news-180223-gsk_zwalnia_caly_dzial_it_w_poznaniu_kilkaset_osob_straci_prace
#GSK #GlaxoSmithKline #bigpharma #pharma #technology #layoffs #Poland #Polska #Poznań
-
GSK lays off over 500 employees in Poland
The whole IT department is getting closed down.
https://epoznan.pl/news-news-180223-gsk_zwalnia_caly_dzial_it_w_poznaniu_kilkaset_osob_straci_prace
#GSK #GlaxoSmithKline #bigpharma #pharma #technology #layoffs #Poland #Polska #Poznań
-
GSK lays off over 500 employees in Poland
The whole IT department is getting closed down.
https://epoznan.pl/news-news-180223-gsk_zwalnia_caly_dzial_it_w_poznaniu_kilkaset_osob_straci_prace
#GSK #GlaxoSmithKline #bigpharma #pharma #technology #layoffs #Poland #Polska #Poznań
-
Die angekündigte Schließung des Dresdner Serumwerks von #GlaxoSmithKline und der damit verbundene Verlust von rund 640 Arbeitsplätzen waren heute Thema im Sächsischen Landtag. Dazu erklärt der #BÜNDNISGRÜNE Abgeordnete #ThomasLöser
www.gruene-fraktion-sachsen.de/presse/press...
Zur angekündigten Schließung d... -
https://www.europesays.com/britain/122118/ Vaccine production site in Germany’s Dresden to close after 115 years #Dresden #FluVaccines #GlaxoSmithKline #GSK #PharmaceuticalCompany #production #VaccineProduction
-
Vaccine production site in Germany’s Dresden to close after 115 years
The GlaxoSmithKline (GSK) logo can be seen in front of the Dresden serum plant. According to the union,…
#Germany #DE #Europe #EU #Europa #Dresden #fluvaccines #GlaxoSmithKline #pharmaceuticalcompany #Production #Vaccineproduction
https://www.europesays.com/germany/88955/ -
GlaxoSmithKline kündigt Schließung von Werk in Dresden an – 650 Mitarbeiter betroffen
AUDIO: GlaxoSmithKline will Impfstoffwerk in Dresden schließen (1 Min) 650 Arbeitsplätze von MDR SACHSEN Stand: 10.09.2026 19:31 Uhr…
#Dresden #Deutschland #Deutsch #DE #Schlagzeilen #Headlines #Nachrichten #News #Europe #Europa #EU #Germany #Glaxosmithkline #Impfstoffe #pharma #Sachsen #Schließung #Unternehmen #Werk
https://www.europesays.com/de/1293164/ -
Pharma-Schock in Dresden: GSK will Impfstoff-Werk mit 641 Arbeitsplätzen schließen. Gewerkschaft kündigt Widerstand an.
https://oiger.de/2026/09/10/glaxosmithkline-schliesst-impfstoffwerk-in-dresden/198506
#GlaxoSmithKline #GSK #Dresden #Impfstoff #IGBCE #Schließung #Arbeitsplätze #Wirtschaft #Pharma -
Pharma-Schock in Dresden: GSK will Impfstoff-Werk mit 641 Arbeitsplätzen schließen. Gewerkschaft kündigt Widerstand an.
https://oiger.de/2026/09/10/glaxosmithkline-schliesst-impfstoffwerk-in-dresden/198506
#GlaxoSmithKline #GSK #Dresden #Impfstoff #IGBCE #Schließung #Arbeitsplätze #Wirtschaft #Pharma -
Pharma-Schock in Dresden: GSK will Impfstoff-Werk mit 641 Arbeitsplätzen schließen. Gewerkschaft kündigt Widerstand an.
https://oiger.de/2026/09/10/glaxosmithkline-schliesst-impfstoffwerk-in-dresden/198506
#GlaxoSmithKline #GSK #Dresden #Impfstoff #IGBCE #Schließung #Arbeitsplätze #Wirtschaft #Pharma -
Pharma-Schock in Dresden: GSK will Impfstoff-Werk mit 641 Arbeitsplätzen schließen. Gewerkschaft kündigt Widerstand an.
https://oiger.de/2026/09/10/glaxosmithkline-schliesst-impfstoffwerk-in-dresden/198506
#GlaxoSmithKline #GSK #Dresden #Impfstoff #IGBCE #Schließung #Arbeitsplätze #Wirtschaft #Pharma -
Schließungspläne: GSK will Impfstoffwerk Dresden schließen
Der Pharmakonzern GlaxoSmithKline (GSK) will seinen Standort in Dresden bis zum Sommer 2028 schließen. Die Produktion von Grippeimpfstoffen…
#Dresden #Deutschland #Deutsch #DE #Schlagzeilen #Headlines #Nachrichten #News #Europe #Europa #EU #Germany #Glaxosmithkline #GSK #Impfstoffwerk #Pharmakonzern #Sachsen #Schließungsplan #Schließungspläne
https://www.europesays.com/de/1292867/ -
https://www.europesays.com/africa/414515/ Uber’s exit exposes mirage of Tinubu’s $1 trillion economy #BoltFood #DeliFoods #Diageo #Equinox #ErrandProducts #FramanIndustries #GlaxoSmithKline #JumiaFood #KimberlyClark #Microsoft #Mother’sPride #MufexNigeria #NASCO #Nigeria #PickNPay #Procter&Gamble #PZCussons #SanofiAventis #Shoprite #StandardBiscuits #StoneIndustries #SurestFoam #TotalEnergies #TowerAluminum #Unilever #UnionTrading #UniversalRubber
-
HUTCHMED Secures $110 Million Licensing Deal with GSK for Promising Solid Tumour Drug, ETPharma
Shanghai: GSK subsidiary GlaxoSmithKline Intellectual Property (No. 4) Ltd will pay a unit of HUTCHMED (China) $110 million…
#EuropeSays #Britain #Europe #EU #GSK #experimentalsolidtumourdrug #GlaxoSmithKline #HMPL-A830 #HUTCHMEDlicensingdeal #solidtumours
https://www.europesays.com/britain/117654/ -
https://www.europesays.com/britain/117654/ HUTCHMED Secures $110 Million Licensing Deal with GSK for Promising Solid Tumour Drug, ETPharma #ExperimentalSolidTumourDrug #GlaxoSmithKline #GSK #HMPLA830 #HUTCHMEDLicensingDeal #SolidTumours
-
https://www.europesays.com/ie/665590/ New tool predicts heart failure treatment effects on blood pressure, kidney function and serum potassium #Angiotensin #blood #BloodPressure #BodyMassIndex #cardiology #ClinicalTrial #Diagnostics #Éire #Enzyme #GlaxoSmithKline #GlobalHealth #Glucose #Heart #HeartFailure #IE #Ireland #Kidney #LowBloodPressure #medicine #Mortality #pharmaceuticals #Potassium #Receptor #Research #Technology #therapy
-
OliX Pharmaceuticals Hires Former GSK Executive Min Ji-young as CDO to Accelerate Global RNAi Development — BigGo Finance
OliX Pharmaceuticals, a company specializing in RNA interference (RNAi)-based drug development, has brought on a development expert from…
#EuropeSays #Britain #Europe #EU #GSK #GlaxoSmithKline(GSK) #InstitutPasteurKorea #MinJi-young #OASISplatform #OliXPharmaceuticals #OLX104C #OLX301A #OLX501A #OLX702A #RNAi #U.S.NationalInstitutesofHealth(NIH)
https://www.europesays.com/britain/100432/ -
https://www.europesays.com/britain/100432/ OliX Pharmaceuticals Hires Former GSK Executive Min Ji-young as CDO to Accelerate Global RNAi Development — BigGo Finance #GlaxoSmithKline(GSK) #GSK #InstitutPasteurKorea #MinJiYoung #OASISPlatform #OliXPharmaceuticals #OLX104C #OLX301A #OLX501A #OLX702A #RNAi #USNationalInstitutesOfHealth(NIH)
-
https://www.europesays.com/britain/93909/ GSK Announces £400m Investment in Cambridge Hub #AndyBurnham #CambridgeScienceHub #CambridgeUniversity #GlaxoSmithKline #GSK #OxfordUniversity
-
Nuvalent director’s awards cashed out in GSK deal
SEC Form 4 FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP…
#EuropeSays #Britain #Europe #EU #GSK #Form4 #GlaxoSmithKline #InsiderTrading #merger #Nuvalent #NUVL #OfferPrice #SapnaSrivastava #stockoptions #tenderoffer
https://www.europesays.com/britain/83997/ -
https://www.europesays.com/britain/83997/ Nuvalent director’s awards cashed out in GSK deal #Form4 #GlaxoSmithKline #GSK #InsiderTrading #merger #Nuvalent #NUVL #OfferPrice #SapnaSrivastava #StockOptions #TenderOffer
-
https://www.europesays.com/ie/536405/ New mRNA flu vaccine offers broader protection against influenza strains #Antibodies #Antibody #BCell #Cell #Efficacy #Éire #flu #food #Genetic #Genome #GlaxoSmithKline #Health #IE #ImmuneResponse #ImmuneSystem #immunity #Immunology #Influenza #Ireland #Laboratory #Manufacturing #medicine #Pathology #PublicHealth #Research #Technology #Therapeutics #Vaccine #virus
-
Wow, I always assumed Ribena was made by some "normal" beverage group like Nestlé or something. Turns out it was originally made by one of the predecessors of GlaxoSmithKline and stayed with GSK for a while. I guess it makes sense if you look at it less like a beverage and more like a remedy.
Now it's with Suntory, an actual beverage company.
-
Wow, I always assumed Ribena was made by some "normal" beverage group like Nestlé or something. Turns out it was originally made by one of the predecessors of GlaxoSmithKline and stayed with GSK for a while. I guess it makes sense if you look at it less like a beverage and more like a remedy.
Now it's with Suntory, an actual beverage company.
-
Wow, I always assumed Ribena was made by some "normal" beverage group like Nestlé or something. Turns out it was originally made by one of the predecessors of GlaxoSmithKline and stayed with GSK for a while. I guess it makes sense if you look at it less like a beverage and more like a remedy.
Now it's with Suntory, an actual beverage company.
-
Wow, I always assumed Ribena was made by some "normal" beverage group like Nestlé or something. Turns out it was originally made by one of the predecessors of GlaxoSmithKline and stayed with GSK for a while. I guess it makes sense if you look at it less like a beverage and more like a remedy.
Now it's with Suntory, an actual beverage company.
-
https://www.europesays.com/britain/50564/ Suddenly investors can’t get enough of GSK shares! What’s going on? #GlaxoSmithKline #GSK #GSKShares
-
… and the „Goldenes Zäpfchen“ 2026 goes to GlaxoSmithKline. 🎉
Im Rahmen unserer diesjährigen Fachtagung „Arzneimittelversorgung mit Zukunft – Was brauchen wir wirklich?“ am 14. März in Göttingen haben wir unseren Negativpreis in diesem Jahr an den Pharmakonzern #GlaxoSmithKline verliehen.
Wir kritisieren deren indirekte #Laienwerbung für #Impfstoff gegen #Gürtelrose und rügen das Unternehmen, mit emotionalisierenden Kampagnen Ängste zu schüren, und so die Nachfrage nach dem Impfstoff zu steigern.
MEZIS fordert eine gesetzliche Nachschärfung des #Heilmittelwerbegesetzes zum besseren Schutz vor #Einflussnahme im #Gesundheitswesen.
Mehr in unserer aktuellen Pressemitteilung unter: https://mezis.de/mezis-negativpreis-goldenes-zaepfchen-an-den-pharmakonzern-glaxosmithkline-vergeben/
-
https://www.europesays.com/ie/382674/ Defining the limits of immunotherapy in early small-cell lung cancer #Biotechnology #cancer #Cell #Chemoradiotherapy #chemotherapy #ClinicalTrial #Diagnostics #Éire #GlaxoSmithKline #hospital #IE #immunotherapy #Ireland #LungCancer #medicine #oncology #pharmaceuticals #RadiationTherapy #Research #Science #SmallCellLungCancer #Therapeutics #therapy
-
Il y a 14 ans : Les échantillons des JO-2012 pourront être testés pendant huit ans https://www.cyclisme-dopage.com/actualite/2012-03-06-lexpress-fr.htm #cyclisme #dopage #JO #Londres2012 #GlaxoSmithKline
-
Il y a 14 ans : Les échantillons des JO-2012 pourront être testés pendant huit ans https://www.cyclisme-dopage.com/actualite/2012-03-06-lexpress-fr.htm #cyclisme #dopage #JO #Londres2012 #GlaxoSmithKline
-
Myron Cohen, 75, reviews a life lived alongside HIV https://www.byteseu.com/1796464/ #aids #CDC #GlaxoSmithKline #Health #hemophilia #HIV #HumanImmunodeficiencyVirus #InfectiousDisease #measles #NationalInstitutesForHealth #prep #UNCChapelHill
-
#Petition #Letter #GlaxoSmithKline
"To: GlaxoSmithKline
We’ve noticed you’ve quietly benefited from £3.4 billion in tax breaks via the Government’s patent box scheme
The scheme was meant to boost innovation and protect jobs, but instead you’ve cut UK jobs and moved manufacturing abroad
So this is an invoice for the full amount you’ve benefitted to date for your broken promises. It’s what you owe us, and our NHS"Please consider signing this open letter
https://act.38degrees.org.uk/act/Sign-the-invoice-to-GlaxoSmithKline
-
#Petition #Letter #GlaxoSmithKline
"To: GlaxoSmithKline
We’ve noticed you’ve quietly benefited from £3.4 billion in tax breaks via the Government’s patent box scheme
The scheme was meant to boost innovation and protect jobs, but instead you’ve cut UK jobs and moved manufacturing abroad
So this is an invoice for the full amount you’ve benefitted to date for your broken promises. It’s what you owe us, and our NHS"Please consider signing this open letter
https://act.38degrees.org.uk/act/Sign-the-invoice-to-GlaxoSmithKline
-
#Petition #Letter #GlaxoSmithKline
"To: GlaxoSmithKline
We’ve noticed you’ve quietly benefited from £3.4 billion in tax breaks via the Government’s patent box scheme
The scheme was meant to boost innovation and protect jobs, but instead you’ve cut UK jobs and moved manufacturing abroad
So this is an invoice for the full amount you’ve benefitted to date for your broken promises. It’s what you owe us, and our NHS"Please consider signing this open letter
https://act.38degrees.org.uk/act/Sign-the-invoice-to-GlaxoSmithKline
-
#Petition #Letter #GlaxoSmithKline
"To: GlaxoSmithKline
We’ve noticed you’ve quietly benefited from £3.4 billion in tax breaks via the Government’s patent box scheme
The scheme was meant to boost innovation and protect jobs, but instead you’ve cut UK jobs and moved manufacturing abroad
So this is an invoice for the full amount you’ve benefitted to date for your broken promises. It’s what you owe us, and our NHS"Please consider signing this open letter
https://act.38degrees.org.uk/act/Sign-the-invoice-to-GlaxoSmithKline
-
Sign the invoice to #GlaxoSmithKline
To: GlaxoSmithKline
We’ve noticed you’ve quietly benefited from £3.4 billion in #tax breaks via Govts patent box scheme
Scheme was meant to boost innovation & protect jobs, but instead you’ve cut #UK#jobs & moved manufacturing abroad
That money could have gone to #NHS #hospitals, training for NHS #nurses, #doctors, or towards care for loved ones
Sign invoice
https://act.38degrees.org.uk/act/Sign-the-invoice-to-GlaxoSmithKline?utm_source=Mastodon#SaveOurNHS #greed #corruption #CorporateGreed #unemployment #medication
-
Sign the invoice to #GlaxoSmithKline
To: GlaxoSmithKline
We’ve noticed you’ve quietly benefited from £3.4 billion in #tax breaks via Govts patent box scheme
Scheme was meant to boost innovation & protect jobs, but instead you’ve cut #UK#jobs & moved manufacturing abroad
That money could have gone to #NHS #hospitals, training for NHS #nurses, #doctors, or towards care for loved ones
Sign invoice
https://act.38degrees.org.uk/act/Sign-the-invoice-to-GlaxoSmithKline?utm_source=Mastodon#SaveOurNHS #greed #corruption #CorporateGreed #unemployment #medication
-
Sign the invoice to #GlaxoSmithKline
To: GlaxoSmithKline
We’ve noticed you’ve quietly benefited from £3.4 billion in #tax breaks via Govts patent box scheme
Scheme was meant to boost innovation & protect jobs, but instead you’ve cut #UK#jobs & moved manufacturing abroad
That money could have gone to #NHS #hospitals, training for NHS #nurses, #doctors, or towards care for loved ones
Sign invoice
https://act.38degrees.org.uk/act/Sign-the-invoice-to-GlaxoSmithKline?utm_source=Mastodon#SaveOurNHS #greed #corruption #CorporateGreed #unemployment #medication
-
Sign the invoice to #GlaxoSmithKline
To: GlaxoSmithKline
We’ve noticed you’ve quietly benefited from £3.4 billion in #tax breaks via Govts patent box scheme
Scheme was meant to boost innovation & protect jobs, but instead you’ve cut #UK#jobs & moved manufacturing abroad
That money could have gone to #NHS #hospitals, training for NHS #nurses, #doctors, or towards care for loved ones
Sign invoice
https://act.38degrees.org.uk/act/Sign-the-invoice-to-GlaxoSmithKline?utm_source=Mastodon#SaveOurNHS #greed #corruption #CorporateGreed #unemployment #medication
-
https://www.europesays.com/es/198557/ El inhalador de bajas emisiones de carbono de GSK logra datos positivos del ensayo pivotal en fase III #asma #eficacia #ES #España #GlaxoSmithKline(GSK) #Health #Inmunología #Innovación #Investigación #InvestigaciónYDesarrollo(I+D) #Respiratorio #Salbutamol #Salud #seguridad #sostenibilidad #Spain #universidad
-
Scientists discover molecular brake that limits T cell attack on tumors
In a discovery that could expand the array of current cancer immunotherapy treatments, scientists at Harvard Medical School…
#NewsBeep #News #Health #AU #Australia #Cancer #CancerImmunotherapy #Cell #CRISPR #Cytokine #Cytokines #Gene #Genomics #GlaxoSmithKline #ImmuneSystem #Immunology #Immunotherapy #MedicalSchool #Molecule #protein #research #T-Cell #Therapeutics #Tumor
https://www.newsbeep.com/au/111000/ -
GSK signs £50m deal with Oxford University on cancer vaccines https://www.theguardian.com/business/2025/jan/27/gsk-deal-oxford-university-cancer-vaccines #Pharmaceuticalsindustry #UniversityofOxford #GlaxoSmithKline #Medicalresearch #Cancerresearch #Education #Business #Science #UKnews
-
GSK signs £50m deal with Oxford University on cancer vaccines https://www.theguardian.com/business/2025/jan/27/gsk-deal-oxford-university-cancer-vaccines #Pharmaceuticalsindustry #UniversityofOxford #GlaxoSmithKline #Medicalresearch #Cancerresearch #Education #Business #Science #UKnews
-
GSK signs £50m deal with Oxford University on cancer vaccines https://www.theguardian.com/business/2025/jan/27/gsk-deal-oxford-university-cancer-vaccines #Pharmaceuticalsindustry #UniversityofOxford #GlaxoSmithKline #Medicalresearch #Cancerresearch #Education #Business #Science #UKnews
-
GSK signs £50m deal with Oxford University on cancer vaccines https://www.theguardian.com/business/2025/jan/27/gsk-deal-oxford-university-cancer-vaccines #Pharmaceuticalsindustry #UniversityofOxford #GlaxoSmithKline #Medicalresearch #Cancerresearch #Education #Business #Science #UKnews
-
By 2019 popular non prescription #heartburn #medication #Zantac was recalled from retail after it was found to contain an #antihistamine that blocks the release of stomach acid called N-nitrosodimethylamine (#NDMA) that is linked to causing #cancer.
#Drug Mfgr #GSK has reached $2.2bn #legalsettlement in US that is supposed to cover 93% of user cases brought thus far.
Previously #GlaxoSmithKline had paid $70m to settle with the lab that discovered the issue, and other big #drugmakers that also marketed the #OTC drug, including #Pfizer and #Sanofi, have already reached sizable settlements.
https://on.ft.com/4eBVq5g #FinancialTimes #GiftLink #Legal #ProductLiability
-
«23andMe is on the brink. What happens to all its DNA data?»
https://www.npr.org/2024/10/03/g-s1-25795/23andme-data-genetic-dna-privacy
• 23andMe, a genetic testing company, is facing financial difficulties and its customers are concerned about the fate of their #genetic data.
• The company has collected genetic data from 15 million customers.
• There are concerns about the lack of federal protections for genetic data.
• 23andMe has an agreement with #GlaxoSmithKline to use customer data for drug development. -
«23andMe is on the brink. What happens to all its DNA data?»
https://www.npr.org/2024/10/03/g-s1-25795/23andme-data-genetic-dna-privacy
• 23andMe, a genetic testing company, is facing financial difficulties and its customers are concerned about the fate of their #genetic data.
• The company has collected genetic data from 15 million customers.
• There are concerns about the lack of federal protections for genetic data.
• 23andMe has an agreement with #GlaxoSmithKline to use customer data for drug development. -
#GlaxoSmithKline #tuberculosis #vaccines
ProPublica:
How a Big Pharma Company Stalled a Potentially Lifesaving Vaccine in Pursuit of Bigger Profits"A vaccine against tuberculosis, the world’s deadliest infectious disease, has never been closer to reality, with the potential to save millions of lives. But its development slowed after its corporate owner focused on more profitable vaccines."
https://www.propublica.org/article/how-big-pharma-company-stalled-tuberculosis-vaccine-to-pursue-bigger-profits -
#GlaxoSmithKline #tuberculosis #vaccines
ProPublica:
How a Big Pharma Company Stalled a Potentially Lifesaving Vaccine in Pursuit of Bigger Profits"A vaccine against tuberculosis, the world’s deadliest infectious disease, has never been closer to reality, with the potential to save millions of lives. But its development slowed after its corporate owner focused on more profitable vaccines."
https://www.propublica.org/article/how-big-pharma-company-stalled-tuberculosis-vaccine-to-pursue-bigger-profits -
#HIVAIDS #GlaxoSmithKline #ViiVHealthcare
The Guardian:
People with HIV offered hope of self-injected drug at home"GSK-controlled company works on developing patient-administered treatment by end of the decade."
https://www.theguardian.com/business/2023/sep/28/hiv-drug-self-injected-home-treatment-gsk-viiv-healthcare-cabotegravir -
#HIVAIDS #GlaxoSmithKline #ViiVHealthcare
The Guardian:
People with HIV offered hope of self-injected drug at home"GSK-controlled company works on developing patient-administered treatment by end of the decade."
https://www.theguardian.com/business/2023/sep/28/hiv-drug-self-injected-home-treatment-gsk-viiv-healthcare-cabotegravir -
EU genehmigt ersten Impfstoff gegen häufiges Atemwegsvirus https://www.euractiv.de/section/gesundheit/news/eu-genehmigt-ersten-impfstoff-gegen-haeufiges-atemwegsvirus/?utm_source=dlvr.it&utm_medium=mastodon #BioNTechPfizer #EUKommisison #Forschung #GlaxoSmithKline #Impfung
-
Wer denkt sich so einen Unfug aus?
Man muss an dem Blister zuerst das Deckpapier abknibbeln um dann erst die Tablette aus dem Blister drücken zu können.
#glaxosmithkline kann bitte gleich Blutdrucksenker mit in den Karton werfen, damit diejenigen,die die #Tabletten stellen, nicht am geplatzten Kopf sterben 🤬😤
-
Wer denkt sich so einen Unfug aus?
Man muss an dem Blister zuerst das Deckpapier abknibbeln um dann erst die Tablette aus dem Blister drücken zu können.
#glaxosmithkline kann bitte gleich Blutdrucksenker mit in den Karton werfen, damit diejenigen,die die #Tabletten stellen, nicht am geplatzten Kopf sterben 🤬😤
-
Die Weltgesundheitsorganisation hat zum bevorstehenden internationalen Malaria-Tag eine positive Bilanz eines Pilotprojekts in Ghana, Kenia und Malawi vorgestellt. Und die Prognosen sehen noch besser aus.
WHO: Eine Million Kinder in Afrika gegen Malaria geimpft | DW | 21.04.2022
#Malaria #WHO #Impfstoff #TedrosAdhanomGhebreyesus #Afrika #GlaxoSmithKline #Mosquirix